4.7 Article

Weight loss and dropout during a commercial weight-loss program including a very-low-calorie diet, a low-calorie diet, or restricted normal food: observational cohort study

期刊

AMERICAN JOURNAL OF CLINICAL NUTRITION
卷 96, 期 5, 页码 953-961

出版社

AMER SOC NUTRITION-ASN
DOI: 10.3945/ajcn.112.038265

关键词

-

资金

  1. Itrim International

向作者/读者索取更多资源

Background: The effectiveness of commercial weight-loss programs consisting of very-low-calorie diets (VLCDs) and low-calorie diets (LCDs) is unclear. Objective: The aim of the study was to quantify weight loss and dropout during a commercial weight-loss program in Sweden (Itrim; cost: $1300/(sic)1000; all participants paid their own fee). Design: This observational cohort study linked commercial weight-loss data with National Health Care Registers. Weight loss was induced with a 500-kcal liquid-formula VLCD [n = 3773; BMI (in kg/m(2)): 34 +/- 5 (mean +/- SD); 80% women; 45 +/- 12 y of age (mean +/- SD)], a 1200-1500-kcal formula and food-combination LCD (n = 4588; BMI: 30 +/- 4; 86% women; 50 +/- 11 y of age), and a 1500-1800-kcal/d restricted normal-food diet (n = 676; BMI: 29 +/- 5; 81% women; 51 +/- 12 y of age). Maintenance strategies included exercise and a calorie-restricted diet. Weight loss was analyzed by using an intention-to-treat analysis (baseline substitution). Results: After 1 y, mean (+/- SD) weight changes were -11.4 +/- 9.1 kg with the VLCD (18% dropout), -6.8 +/- 6.4 kg with the LCD (23% dropout), and -5.1 +/- 5.9 kg with the restricted normal-food diet (26% dropout). In an adjusted analysis, the VLCD group lost 2.8 kg (95% CI: 2.5, 3.2) and 3.8 kg (95% CI: 3.2, 4.5) more than did the LCD and restricted normal-food groups, respectively. A high baseline BMI and rapid initial weight loss were both independently associated with greater 1-y weight loss (P < 0.001). Younger age and low initial weight loss predicted an increased dropout rate (P < 0.001). Treatment of depression (OR: 1.4; 95% CI: 1.1, 1.9) and psychosis (OR: 2.6; 95% CI: 1.1, 6.3) were associated with an increased dropout rate in the VLCD group. Conclusion: A commercial weight-loss program, particularly one using a VLCD, was effective at reducing body weight in self-selected, self-paying adults. Am J Clin Nutr 2012;96:953-61.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Opioid Use After Gastric Bypass, Sleeve Gastrectomy or Intensive Lifestyle Intervention

Stefan Wallen, Gustaf Bruze, Johan Ottosson, Claude Marcus, Johan Sundstrom, Eva Szabo, Torsten Olbers, Maria Palmetun-Ekback, Ingmar Naslund, Martin Neovius

Summary: This study aimed to compare the use of opioids in patients with obesity who underwent bariatric surgery versus those who underwent intensive lifestyle modification. The results showed that patients who underwent bariatric surgery had a higher proportion of opioid users and a larger total opioid dose, especially in those who received additional surgery during follow-up.

ANNALS OF SURGERY (2023)

Article Medicine, General & Internal

Exploring the causal effect of maternal pregnancy adiposity on offspring adiposity: Mendelian randomisation using polygenic risk scores

Tom A. Bond, Rebecca C. Richmond, Ville Karhunen, Gabriel Cuellar-Partida, Maria Carolina Borges, Verena Zuber, Alexessander Couto Alves, Dan Mason, Tiffany C. Yang, Marc J. Gunter, Abbas Dehghan, Ioanna Tzoulaki, Sylvain Sebert, David M. Evans, Alex M. Lewin, Paul F. O'Reilly, Deborah A. Lawlor, Marjo-Riitta Jarvelin

Summary: This study investigates the causal relationship between maternal pre-/early pregnancy BMI and offspring adiposity. The results suggest that higher maternal BMI is not a key driver of higher adiposity in the next generation.

BMC MEDICINE (2022)

Letter Allergy

Reliability of external impulse oscillometry reference values for assessing respiratory health in Swedish adults

Andrei Malinovschi, Xingwu Zhou, Christer Janson, Johan Sundstrom, Per Wollmer, Jenny Hallberg

CLINICAL AND EXPERIMENTAL ALLERGY (2022)

Article Cardiac & Cardiovascular Systems

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure

Sok Cin Tye, Niels Jongs, Steven G. Coca, Johan Sundstrom, Clare Arnott, Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Priya Vart, Hiddo J. L. Heerspink

Summary: Initiating the SGLT2 inhibitor canagliflozin based on an estimated risk-guided approach, using clinical characteristics and novel biomarkers, can prevent more kidney and heart failure outcomes compared to a strategy based solely on HbA1c or UACR. There is no apparent benefit from adding novel biomarkers to the clinical risk model.

CARDIOVASCULAR DIABETOLOGY (2022)

Article Genetics & Heredity

Loci for insulin processing and secretion provide insight into type 2 diabetes risk

K. Alaine Broadaway, Xianyong Yin, Alice Williamson, Victoria A. Parsons, Emma P. Wilson, Anne H. Moxley, Swarooparani Vadlamudi, Arushi Varshney, Anne U. Jackson, Vasudha Ahuja, Stefan R. Bornstein, Laura J. Corbin, Graciela E. Delgado, Om P. Dwivedi, Lilian Fernandes Silva, Timothy M. Frayling, Harald Grallert, Stefan Gustafsson, Liisa Hakaste, Ulf Hammar, Christian Herder, Sandra Herrmann, Kurt Hojlund, David A. Hughes, Marcus E. Kleber, Cecilia M. Lindgren, Ching-Ti Liu, Jian'an Luan, Anni Malmberg, Angela P. Moissl, Andrew P. Morris, Nikolaos Perakakis, Annette Peters, John R. Petrie, Michael Roden, Peter E. H. Schwarz, Sapna Sharma, Angela Silveira, Rona J. Strawbridge, Tiinamaija Tuomi, Andrew R. Wood, Peitao Wu, Bjorn Zethelius, Damiano Baldassarre, Johan G. Eriksson, Tove Fall, Jose C. Florez, Andreas Fritsche, Bruna Gigante, Anders Hamsten, Eero Kajantie, Markku Laakso, Jari Lahti, Deborah A. Lawlor, Lars Lind, Winfried Maerz, James B. Meigs, Johan Sundstrom, Nicholas J. Timpson, Robert Wagner, Mark Walker, Nicholas J. Wareham, Hugh Watkins, Ines Barroso, Stephen O'Rahilly, Niels Grarup, Stephen CJ. Parker, Michael Boehnke, Claudia Langenberg, Eleanor Wheeler, Karen L. Mohlke

Summary: Insufficient insulin secretion and increased proinsulin levels indicate beta-cell stress and insulin resistance. A meta-analysis of European-ancestry individuals identified 36 independent signals at 30 loci associated with fasting proinsulin. These loci are involved in various mechanisms that affect insulin processing and beta-cell function. Colocalization analysis provided potential candidate genes and regulatory mechanisms for proinsulin production and glucose regulation. This study highlights the importance of genetic studies for understanding disease predisposition.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Article Gastroenterology & Hepatology

Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease

Tracey G. Simon, Bjorn Roelstraete, Naim Alkhouri, Hannes Hagstrom, Johan Sundstrom, Jonas F. Ludvigsson

Summary: This study found that children and young adults with biopsy-proven NAFLD had significantly higher rates of incident MACE, including ischaemic heart disease and congestive heart failure, compared to matched population controls.
Article Public, Environmental & Occupational Health

Low prevalence of ideal cardiovascular health in the general Swedish population: Results from the Swedish CArdioPulmonary bioImage Study (SCAPIS)

Sara Higueras-Fresnillo, Angel Herraiz-Adillo, Viktor H. Ahlqvist, Daniel Berglind, Cecilia Lenander, Bledar Daka, Maria Braennholm Syrjala, Johan Sundstrom, Carl Johan Ostgren, Karin Radholm, Pontus Henriksson

Summary: The aim of this study was to examine the prevalence of ideal cardiovascular health (iCVH) in the middle-aged population of Sweden. Data from a large population-based study were analyzed and a total iCVH score was calculated based on seven components. Results showed that only 18.2% of the population reached ideal status, while 51.9% were classified as intermediate status and 29.9% as poor status of iCVH. Women had a higher prevalence of iCVH status and a lower prevalence of poor iCVH status. These findings can be used as benchmarks for future comparisons and efforts to promote cardiovascular health.

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2023)

Article Cardiac & Cardiovascular Systems

Large-Scale Metabolomics and the Incidence of Cardiovascular Disease

Lars Lind, Tove Fall, Johan Arnlov, Solve Elmstahl, Johan Sundstrom

Summary: This study explored the relationship between a wide range of circulating metabolites and future cardiovascular disease (CVD) as well as subclinical markers of CVD in the general population.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)

Troels Yndigegn, Bertil Lindahl, Joakim Alfredsson, Jocelyne Benatar, Lisa Brandin, David Erlinge, Urban Haaga, Claes Held, Pelle Johansson, Patric Karlstrom, Thomas Kellerth, Toomas Marandi, Katarina Mars, Annica Ravn-Fischer, Johan Sundstrom, Ollie Ostlund, Robin Hofmann, Tomas Jernberg

Summary: This article introduces a trial called REDUCE-AMI, which aims to evaluate the effect of long-term beta-blocker treatment on death and recurrent myocardial infarction in patients with acute MI. The study will involve 5000 patients and observe both primary and secondary endpoints. The results will have important implications for guidelines and clinical practice.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

Article Cardiac & Cardiovascular Systems

Prevalence, outcomes and costs of a contemporary, multinational population with heart failure

Anna Norhammar, Johan Bodegard, Marc Vanderheyden, Navdeep Tangri, Avraham Karasik, Aldo Pietro Maggioni, Kari Anne Sveen, Tiago Taveira-Gomes, Manuel Botana, Lukas Hunziker, Marcus Thuresson, Amitava Banerjee, Johan Sundstrom, Andreas Bollmann

Summary: The CaReMe HF study collected individual level data from digital healthcare systems in 11 countries to estimate the prevalence, clinical outcomes, and costs of HF. The study found that 1-2% of the contemporary adult population has HF, and these individuals are at significant risk of adverse outcomes and associated costs.
Article Medicine, General & Internal

Child and adolescent obesity

Natalie B. B. Lister, Louise A. A. Baur, Janine F. F. Felix, Andrew J. J. Hill, Claude Marcus, Thomas Reinehr, Carolyn Summerbell, Martin Wabitsch

Summary: The prevalence of child and adolescent obesity has plateaued at high levels in most high-income countries and is increasing in many low-income and middle-income countries. Obesity arises when a mix of genetic and epigenetic factors, behavioural risk patterns and broader environmental and sociocultural influences affect the two body weight regulation systems. Treatment incorporates a respectful, stigma-free and family-based approach involving multiple components, and addresses dietary, physical activity, sedentary and sleep behaviours. Prevention of obesity requires a whole-system approach and joined-up policy initiatives across government departments.

NATURE REVIEWS DISEASE PRIMERS (2023)

Article Cardiac & Cardiovascular Systems

Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction

Joel Ohm, Ralf Kuja-Halkola, Anna Warnqvist, Henrike Haebel, Per H. Skoglund, Johan Sundstroem, Kristina Hambraeus, Tomas Jernberg, Per Svensson

Summary: Low socioeconomic status is associated with worse prognosis after myocardial infarction. This study identified nonparticipation in cardiac rehabilitation, cardiometabolic risk profile, and persistent smoking as mediating factors in the relationship between low income and post-MI recurrent atherosclerotic cardiovascular disease events.

CIRCULATION (2023)

Article Endocrinology & Metabolism

Height and Growth Velocity in Children and Adolescents Undergoing Obesity Treatment: A Prospective Cohort Study

Resthie R. Putri, Pernilla Danielsson, Claude Marcus, Emilia Hagman

Summary: This study aimed to investigate the effect of obesity severity and treatment outcome on growth. It was found that obesity severity is positively associated with height and growth velocity, and successful obesity treatment can normalize the growth velocity pattern. Therefore, a hampered growth spurt should be anticipated during puberty, especially in adolescents with severe obesity, and there is no difference in final height between different levels of obesity.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Psychiatry

The association between exposure to clozapine, olanzapine, and quetiapine and the outcomes perimyocarditis and heart failure: A population-based cohort study

Eric Clapham, Johan Reutfors, Marie Linder, Lena Brandt, Johan Sundstrom, Robert Boden

Summary: The risk of cardiac adverse events following the use of clozapine is debated; however, its risk for chemically related antipsychotics olanzapine and quetiapine is unknown. A Swedish study used registers to analyze the risk of perimyocarditis and heart failure in patients receiving these antipsychotics. The study found that clozapine use was associated with a significantly increased short-term risk of perimyocarditis and an increased long-term risk of heart failure. Olanzapine and quetiapine use did not show an increased risk compared to no antipsychotic treatment.

PSYCHIATRY RESEARCH (2023)

Article Medicine, General & Internal

Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study

Jiangwei Sun, Bjorn Roelstraete, Emma Svennberg, Jonas Halfvarson, Johan Sundstrom, Anders Forss, Ola Olen, Jonas F. Ludvigsson

Summary: This study found that patients with inflammatory bowel disease (IBD) have an increased risk of developing arrhythmias. This increased risk persists even 25 years after the diagnosis of IBD.

PLOS MEDICINE (2023)

暂无数据